Mass Tort Journal

  • Subscribe
  • Search
  • Menu
All Access
  • Home
  • Courtroom News
  • Litigation
  • Breaking News
  • Science & Medicine
  • Policy & Legislation
ALSO SEE

Does Off-Label Promotion Settlement Signal Change in FDA Policy?

Litigation
Reuters | Mar 17, 2016

TVM Maker: Plaintiffs Have Undergone Unnecessary Surgeries to Inflate Claims

A major defendant in the 100,000-case pelvic mesh litigation has subpoenaed the mid-sized Houston law firm AkinMears, as well as several smaller law firms and a company that sells personal-injury claims, seeking documents and testimony related to AkinMears’ acquisition last summer of the smaller firms’ mass torts practices.


The subpoenas – issued Tuesday by American Medical Systems in the consolidated federal court mesh litigation in Charleston, West Virginia – are an unusual development in the long-running case because the medical device company has already agreed to settle most of the claims against it. AMS announced in 2014 that it would pay about $1.6 billion to resolve more than 40,000 filed and unfiled claims by women who alleged its mesh implants caused bleeding, infection and other painful side effects.


Despite the settlement, the company’s defense lawyers have begun challenging some recently filed claims. They contend in court filings that plaintiffs may have undergone unnecessary surgical procedures to make them candidates for bigger settlements. The wide-ranging new subpoenas ask the Florida marketing company, AkinMears and the other law firms to produce documents that may link them to doctors, surgical centers and private investors involved in funding medical procedures for mesh plaintiffs.

Litigation
STAT | Mar 17, 2016

News Organization Moves to Unseal Documents in Kentucky Opioid Litigation

STAT is asking a Kentucky court to make public sealed documents that could provide new information on how Purdue Pharma marketed its potent pain pill OxyContin — including what top executives knew about how addictive it was, and whether they downplayed the risks.


Purdue has faced hundreds of lawsuits and numerous government investigations over its aggressive promotion of OxyContin, which some blame for helping spawn the national opioid abuse crisis. In 2007, three corporate executives and an affiliated company pleaded guilty to fraudulently marketing the drug as less addictive than other pain medications and paid $634 million in fines.

Litigation
Law.com | Mar 17, 2016
Paha_L-Istock-Thinkstock

Spotlight on Fee Disputes in MDLs ($)

Fee fights among plaintiffs attorneys in multidistrict litigation have forced more federal judges in recent cases to wade into the disputes — with practically no case law to guide them.


Within the last year, attorney fee fights in MDLs have erupted in personal injury and wrongful-death cases filed over Durom Cup hip implants, General Motors Co.’s ignition-switch defects and laparoscopic uterine surgical tools called power morcellators. There are few appellate decisions on the matter and, in at least two recent cases, the fights have ended with failed petitions before the U.S. Supreme Court.


“There are huge issues about the governance of MDLs that no Supreme Court has addressed in any satisfying way,” said William Rubenstein, a professor at Harvard Law School who has testified as an expert for those challenging MDL fees. “The fee aspects are one of a subset of questions of how they’re governed that have yet to attract good appellate law. The district court judges are struggling with these issues.”

Litigation
Legal Newsline | Mar 17, 2016
j4m3z-istock-thinkstock

Avandia No Injury Class Action Shut Down by Third Circuit

A federal appeals court has shut down a no-injury class action lawsuit filed against the maker of prescription diabetes drug Avandia.


The U.S. Court of Appeals for the Third Circuit, in a Feb. 12 ruling, upheld the decision of the U.S. District Court for the Eastern District of Pennsylvania.

Litigation
The Wall Street Journal | Mar 15, 2016
seb_ra-Istock-thinkstock

DuPont Fails in Attempt to Use Medieval Law to Dismiss Suit

A Delaware court gave a stamp of approval to the litigation finance industry Wednesday, keeping alive a lawsuit over arguments from that the use of a financier violated ethical laws.


DuPont tried to get an intellectual property suit dismissed on the grounds that the plaintiff’s use of funding from litigation funder Burford Capital ran afoul of the laws of “champerty and maintenance”—concepts dating back to Medieval England when wealthy feudal lords were unfairly backing litigation against their enemies. Champerty laws are meant to prohibit outsiders from controlling litigation that doesn’t benefit them and taking a cut of any win.


The plaintiff in the suit, Charge Injection Technologies Inc., sued DuPont in 2007, claiming the company improperly used and disclosed CIT’s proprietary nano-technology. It wasn’t until 2012 that Burford came into the case, through one of its subsidiaries.

Litigation
Reuters | Mar 15, 2016

VW U.S. CEO Resigns ASAP

Volkswagen AG's top U.S. executive is stepping down nearly six months after the German automaker admitted to installing software to allow 580,000 diesel U.S. vehicles to emit excess emissions, the company said on Wednesday.


Michael Horn, who has been president and chief executive officer of Volkswagen Group of America since 2014, is leaving by mutual agreement "to pursue other opportunities effective immediately," VW said.


The German automaker said on an interim basis, Hinrich J. Woebcken, a former BMW executive who ran global purchasing among other jobs, is filling Horn's job. In January, VW named Woebcken as head of VW's North American region, effective April 1.

Litigation
JD Supra | Mar 15, 2016
Golden_Lady_Justicecreative-commons

BigLaw Attorneys Report on Their Adventures at Mass Torts Made Perfect

Mass Torts Made Perfect is a plaintiff lawyer organization. Every year it conducts a conference in Las Vegas, where plaintiff lawyers get together and plot our clients’ destruction (Okay, that was a bit too melodramatic) That Las Vegas conference is confined to plaintiff lawyers. Defense lawyers are not welcome. Why would they be? But MTMP’s Philly conference is open to defense lawyers. We went to that conference last week. There weren’t too many defense lawyers there. We were heavily outnumbered Still, the plaintiff lawyer hosts were unfailingly hospitable. There were a couple of defense lawyers on some of the panels. We were on a MTMP panel four years ago. As part of that gig, we rendered a spot-on (if we do say so ourselves) impersonation of one of our favorite plaintiff lawyers sidling up to the lectern and shaking his head over the defendant’s “very, very serious” discovery shortcomings. Laughter all around. Oddly, we have not been invited to be on any MTMP panels since then.


It was interesting listening to the plaintiff lawyers. And, yes, we’ll admit that we asked some of them what they thought the next mass tort would be. That part we’re keeping to ourselves, unless you’re a paying client. But there were a couple of things that might be of general interest.


Litigation
Observer | Mar 15, 2016

Profile of Compensation Fund Master Kenneth Feinberg

Think of a cataclysm of the last 20 years, and this lawyer has been on the job.


Since the 1980s, but especially since September 11, 2001, there has been only one attorney in America called upon, again and again, to administer compensation for victims and survivors of the nation’s most spectacular disasters. Think of a calamity during the last decade and a half, and the droopy-faced, balding and bespectacled 70-year-old with a Boston brogue right out of The Departed has been on the job: 9/11, Virginia Tech, the BP oil spill, Sandy Hook, Aurora, the Boston Marathon bombing.


The Democratic attorney, a former chief of staff to Ted Kennedy, specializes in what is dryly called mediation or alternative dispute resolution. In practice, this often means he must decide exactly how much money aggrieved people will receive from the private company, institution or government that could, in the traditional trial system, be found responsible for their suffering.

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 29
  • Next Page »

© 2025 · Mass Tort Journal · All Rights Reserved

  • All Access
  • Courtroom News
  • Litigation
  • Policy & Legislation
  • Science & Medicine
  • Home
  • Breaking News
  • Litigation
  • Courtroom News
  • Science & Medicine
  • Policy & Legislation